Dec 19, 2023
The Foundation for Sarcoidosis Research (FSR) announces $100,000 in funding for support of research aimed at improving diagnosis, management, and treatment of cardiac sarcoidosis. FSR awarded two grants, each in the amount of $50,000, to Senthil Selvaraj, MD, MS, MA,...Topics: News/ Research
Nov 2, 2023
Foundation for Sarcoidosis Research (FSR) announces three clinics that have been selected as members of FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) – a groundbreaking initiative that will have a worldwide impact on advancing sarcoidosis research and improving...Topics: Community Partners/ News/ Research
Sep 5, 2023
With more than 250,000 Americans living with interstitial lung disease (ILD) and pulmonary fibrosis (PF), nine organizations are joining forces to present the third annual ILD Day on Wednesday, Sept. 13, to drive awareness of the diseases. ILD is the umbrella term...Topics: Advocacy/ Awareness/ News/ Online Educational Content/ Research
Jul 26, 2023
The Foundation for Sarcoidosis Research (FSR) is pleased to announce that the FSR Sarcoidosis Research Fellowship for 2023-2025 is being awarded to Dr. Christen Vagts from FSR Global Sarcoidosis Clinic Alliance Founding Member, University of Illinois Hospital and...Topics: News/ Research
May 22, 2023
Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to elevating research, raising awareness and providing support for individuals affected by sarcoidosis, is proud to announce the release of the Ignore No More Campaign on...Topics: Advocacy/ Awareness/ News/ Online Educational Content/ Research
Apr 26, 2023
Recently, we asked our dedicated and generous Sarcoidosis Awareness Campaign Gold Level Sponsor, aTyr Pharma, Inc., to share more about their passion for raising awareness and improving the lives of those impacted by sarcoidosis. Check out how they are accelerating...Topics: Awareness/ Community Partners/ Research
Nov 17, 2022
aTyr Pharma, Inc. is partnering with the Foundation for Sarcoidosis Research (FSR) to recruit for a global pivotal Phase 3 study, EFZO-FIT™, of aTyr’s lead therapeutic candidate, efzofitimod, in patients with pulmonary sarcoidosis. This study comes on...Topics: News/ Research
Nov 17, 2022
The Foundation for Sarcoidosis Research (FSR) is pleased to award Dr. Nabeel Hamzeh, Professor of Internal Medicine – Pulmonary, Critical Care and Occupational Medicine at The University of Iowa, funding for cardiac sarcoidosis research in the amount...Topics: News/ Research
Oct 25, 2022
[su_quote cite=”Calvin Harris”]“My hope is that this campaign will greatly increase awareness of sarcoidosis and encourage Black patients to participate in clinical trials. That will ultimately improve our lives and benefit everyone in the...Topics: Living with Sarcoidosis/ News/ Other/ Patient Voices/ Research/ Take Action
Oct 20, 2022
If you have sarcoidosis, you MUST join the Foundation for Sarcoidosis Research (FSR) Patient Registry. With less than 200,000 of us diagnosed each year, we are the sources of data needed to advance sarcoidosis research. FSR created the Patient Registry to share...Topics: Living with Sarcoidosis/ Research/ Take Action
